Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study in Participants With Obesity or Overweight With at Least One Weight-related Comorbidity
Sponsor: AstraZeneca
Summary
A Phase IIb Randomised, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of AZD6234 compared with placebo, given once a week as subcutaneous injection for 36 weeks, in male and female participants of at least 18 years of age who are living with obesity (body mass index \[BMI\] ≥ 30 kg/m2), or overweight (BMI ≥ 27 kg/m2) and at least one weight-related comorbidity
Official title: A Phase IIb Randomised, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Obesity or Overweight With Comorbidity
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
262
Start Date
2024-10-01
Completion Date
2025-12-03
Last Updated
2026-07-20
Healthy Volunteers
No
Conditions
Interventions
AZD6234
IMP injected subcutaneously, once a week. Unit dose strength as per CSP
Placebo comparator
Placebo matching IMP dose injected subcutaneously, once a week.
Locations (41)
Research Site
Mobile, Alabama, United States
Research Site
Phoenix, Arizona, United States
Research Site
Long Beach, California, United States
Research Site
Hialeah, Florida, United States
Research Site
Largo, Florida, United States
Research Site
Orlando, Florida, United States
Research Site
Tampa, Florida, United States
Research Site
Woodstock, Georgia, United States
Research Site
Indianapolis, Indiana, United States
Research Site
Lutherville-Timonium, Maryland, United States
Research Site
Gulfport, Mississippi, United States
Research Site
Ridgeland, Mississippi, United States
Research Site
Kansas City, Missouri, United States
Research Site
Omaha, Nebraska, United States
Research Site
Portsmouth, New Hampshire, United States
Research Site
Statesville, North Carolina, United States
Research Site
North Charleston, South Carolina, United States
Research Site
Knoxville, Tennessee, United States
Research Site
Austin, Texas, United States
Research Site
Dallas, Texas, United States
Research Site
Port Arthur, Texas, United States
Research Site
San Antonio, Texas, United States
Research Site
San Antonio, Texas, United States
Research Site
Heidelberg, Australia
Research Site
Maroochydore, Australia
Research Site
Maroubra, Australia
Research Site
Merewether, Australia
Research Site
Hamilton, Ontario, Canada
Research Site
Sarnia, Ontario, Canada
Research Site
Stouffville, Ontario, Canada
Research Site
Toronto, Ontario, Canada
Research Site
Montreal, Quebec, Canada
Research Site
Sherbrooke, Quebec, Canada
Research Site
Chūōku, Japan
Research Site
Chūōku, Japan
Research Site
Shinjuku-ku, Japan
Research Site
Suita-shi, Japan
Research Site
Hull, United Kingdom
Research Site
Leicester, United Kingdom
Research Site
Penarth, United Kingdom
Research Site
Rotherham, United Kingdom